KEYTRUDA, Merck, Pembrolizumab, TNBC

Pembrolizumab has been approved by the FDA for high-risk early-stage triple-negative breast cancer

August 2021: Pembrolizumab (Keytruda, Merck) was approved by the FDA for high-risk, early-stage triple-negative breast cancer (TNBC) as a neoadjuvant treatment in combination with chemotherapy, and later as a single agent as adjuv..

Immunomedics Inc, mTNBC, NCT02574455, sacituzumab govitecan, Trodelvy

Sacituzumab govitecan receives FDA approval for triple-negative breast cancer

August 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) gained regular FDA clearance for patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior ..

High tumor burden, Immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H

Pembrolizumab approved for use in any cancer with a high tumor mutational burden

July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a high mutational burden (TMB-H). The new authorization is f..

The safety and effectiveness of olaparib combined with carboplatin in the treatment of triple-negative breast and ovarian cancer

Victoria L. Chiou, an oncologist at the National Cancer Institute ’s Women ’s Malignancies Department, reported a phase I trial at AACR2015. The results showed that olaparib combined with carboplatin had a primary effect on re..

Niraparib

Niraparib achieves amazing results for ovarian and breast cancer

Breast & ovarian cancerIf you are a breast and ovarian cancer patient, you happen to find that you are a cancer of the BRCA1 / 2 mutation after passing the genetic test, and your life is saved. According to the Global Oncolog..

Breast cancer typing and targeted drugs

Breast cancer situation Approximately every 10-12% of breast cancer patients in the world are in India, and nearly two-thirds of patients are diagnosed with advanced cancer at the time of diagnosis. Experts analyzed that there s..

Genetic testing

Breast cancer 21 gene test guides precise treatment

Breast cancer problemBreast cancer is a common female malignant tumor that seriously threatens the physical and mental health of women, so it is also known as the "red killer". Statistics show that breast cancer causes 458,000 de..

Genetic testing

Do you need chemotherapy for breast cancer?

Breast cancer & chemotherapyAmong the many cancers, breast cancer is probably the most difficult to decide whether to undergo chemotherapy after surgery. Similar to other cancers, the factors that determine breast cancer chem..

Clinical trials, USA

Mayo clinic trials triple negative breast cancer vaccine

Mayo ClinicResearchers at the Mayo Clinic Florida campus received a five-year federal grant totaling $ 13 million to test vaccines designed to prevent the recurrence of triple-negative breast cancer. Triple-negative breast cancer..

Brain metastasis in breast cancer

Breast cancer With the advancement of breast cancer diagnosis and treatment, the survival time of breast cancer patients has prolonged significantly, but the incidence of breast cancer brain metastases (BCBM) has gradually increa..